2.04
Gri Bio Inc Aktie (GRI) Neueste Nachrichten
GRI Bio Inc. (GRI) Slides 7% as Shares Test Key Support at $1.96Relative Volume - Newser
GRI Bio Inc. Q1 2026 Earnings: EPS Misses Estimates as Development-Stage Company Faces HeadwindsEarnings Quality Score - Newser
GRI Bio (GRI) Q1 2026 Results Miss Estimates — EPS $-1.61 vs $-0.91Positive Surprise Momentum - Newser
GRI Bio CEO to discuss innovative immune therapies at healthcare showcase May 20 - Pluang
Biotech GRI Bio to outline NKT-cell drug pipeline in live webcast - Stock Titan
Number of shareholders of GRI Bio, Inc. – NASDAQ:GRI - TradingView
GRI Bio (GRI) Falls -5.56% — Watching $1.94 Support 2026-05-15Sector Rotation - Newser
GRI Bio Reports Positive Phase 2a Results for GRI-0621 in IPF and Advances Immune-Modulating Pipeline with Strong Q1 2026 Financials - Minichart
GRI Bio Highlights Promising Phase 2a IPF Data, Outlook - TipRanks
GRI Bio reports phase 2a data for IPF drug candidate GRI-0621 - Investing.com
GRI Bio Q1 net loss narrows on lower R&D expenses - TradingView
IPF Phase 2a results and cash runway update for GRI Bio (NASDAQ: GRI) - Stock Titan
GRI Bio Reports First Quarter 2026 Financial Results, New - GlobeNewswire
H.C. Wainwright Maintains GRI Bio(GRI.US) With Buy Rating, Maintains Target Price $10 - Moomoo
GRI BIO ($GRI) Releases Q1 2026 Earnings - Moomoo
GRI Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView
GRI Bio (GRI) Schedule 13G/A: 90,475 shares represent 5.9% stake - Stock Titan
GRI Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
GRI Bio (NASDAQ: GRI) Q1 loss narrows as cash runway extends into 2027 - Stock Titan
Is GRI Bio (GRI) stock hiding in plain sight? (+1.78%) 2026-05-11Low Volatility Stocks - Newser
GRI Stock Price, Quote & Chart | GRI BIO INC (NASDAQ:GRI) - ChartMill
GRI Bio (GRI) Stock: Is It a Good Portfolio Addition | Q4 2025: Earnings UnderperformReal Trader Insights - newser.com
GRI Bio announces 1-for-28 reverse share split - MSN
GRI Bio (GRI) Stock Consumer Data (-3.14%) 2026-04-24Oversold Bounce - Newser
GRI Bio (GRI) Stock Volume Drought (Tick Down) 2026-04-20Verified Analyst Reports - Cổng thông tin điện tử tỉnh Lào Cai
Market Valuation Insight | GRI Bio reports 294.6% EPS miss and zero revenueEarnings Trend Analysis - Newser
GRI | GRI Bio, Inc. Common Insider Trading - Quiver Quantitative
GRI Bio (GRI) Stock Volume Analysis (Grinds Higher) 2026-04-15Portfolio Ideas - UBND thành phố Hải Phòng
Is GRI Bio (GRI) Stock at a Peak | Price at $2.33, Down 4.90%Golden Cross - Newser
Revenue Check: What makes Friedman Industries Incorporated stock attractive today2026 Highlights & Daily Market Momentum Tracking - baoquankhu1.vn
GRI Bio (GRI) price target decreased by 75.16% to 163.20 - MSN
GRI Bio receives UAE patent for inflammatory disease treatment By Investing.com - Investing.com Australia
Big Picture: Can Euro Tech Holdings Company Limited continue delivering strong returns2026 Sentiment & Community Shared Stock Ideas - baoquankhu1.vn
GRI Springs on UAE Patent - Baystreet.ca
GRI Bio receives UAE patent for inflammatory disease treatment - Investing.com
GRI Bio Receives Notice of Allowance for UAE Patent - GlobeNewswire
Sentiment Review: Is GRI Bio Inc forming a bullish divergence2026 Snapshot & Capital Efficiency Focused Ideas - baoquankhu1.vn
Aug Movers: Is GRI Bio Inc forming a bullish divergence2026 Big Picture & Real-Time Market Sentiment Reports - baoquankhu1.vn
12 Health Care Stocks Moving In Tuesday's Pre-Market SessionAditxt (NASDAQ:ADTX), Advanced Biomed (NAS - Benzinga
GRI Bio Inc. (GRI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Options Flow: Is GRI Bio Inc forming a double bottom2026 Weekly Recap & Stepwise Trade Execution Plans - baoquankhu1.vn
Aug Technicals: Is GRI Bio Inc in a long term uptrend2026 Gainers & AI Driven Price Predictions - baoquankhu1.vn
Options Flow: Can GRI Bio Inc reach all time highs this yearTrade Exit Summary & Smart Money Movement Tracker - baoquankhu1.vn
GRI Bio (NASDAQ:GRI) versus NeoGenomics (NASDAQ:NEO) Financial Contrast - Defense World
Trend Review: Can GRI Bio Inc be recession proof2026 Market Mood & Detailed Earnings Play Strategies - baoquankhu1.vn
Portfolio Recap: Is GRI Bio Inc a top pick in the sectorMarket Activity Recap & Weekly Return Optimization Plans - baoquankhu1.vn
Aug Outlook: Can GRI Bio Inc keep up with sector leaders2026 Final Week & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Movement Recap: Is GRI Bio Inc a momentum stock2026 Setups & Weekly Consistent Profit Watchlists - baoquankhu1.vn
If You Invested $1,000 in GRI Bio (GRI) - Stock Titan
Analyst Calls: Is GRI Bio Inc a top pick in the sectorPortfolio Performance Summary & AI Forecasted Stock Moves - baoquankhu1.vn
AI Investing InsightsOfficial HomepageIntellectia AI™ - intellectia.ai
Aug Retail: Is HOWL a defensive stockWeekly Stock Report & Smart Money Movement Tracker - baoquankhu1.vn
Aug Setups: Will FWRD outperform tech stocksWeekly Trend Recap & Stock Market Timing Techniques - baoquankhu1.vn
Patterns Watch: What are CLMBs earnings expectationsEarnings Performance Report & Trade Opportunity Analysis - baoquankhu1.vn
Se espera que GRI Bio Inc registre una pérdida de 1,31 dólares por acciónAvance de resultados - TradingView
GRI Bio, Inc. Financial Disclosures & SEC Filings - TradingView
GRI Bio (GRI) Analyst Rating Update: Price Target Drastically Lo - GuruFocus
Activity Recap: Can GRI Bio Inc be recession proof2025 Pullback Review & Weekly Setup with High ROI Potential - baoquankhu1.vn
GRI Bio (GRI) Expected to Announce Quarterly Earnings on Friday - Defense World
Update Report: What is OBLGs 5 year growth outlookJuly 2025 Analyst Calls & High Conviction Buy Zone Alerts - baoquankhu1.vn
GRI Bio Reports Positive Study Results For Chronic Lung Disease, But Stock Slumps 20% — What Happened? - Stocktwits
Short Covering: What makes GRI Bio Inc stock attractive todayWeekly Earnings Recap & High Win Rate Trade Tips - baoquankhu1.vn
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):